CALL FOR NOMINATIONS: NAS and NAM Initiative on Human Gene Editing
By Announcement,
Committee On Science, Technology, and Law
| 06. 24. 2015
Untitled Document
The National Academy of Sciences and the National Academy of Medicine are launching a major initiative to guide decision making about controversial new research involving human gene editing. Human gene-editing technologies, such as CRISPR-Cas9, may lead to promising new treatments for disease. However, recent experiments to attempt to edit human genes also have raised important questions about the potential risks and ethical concerns of altering the human germline.
Our initiative will include an international summit in late 2015 to convene researchers and other experts to explore the scientific, ethical, legal, and policy issues associated with human gene-editing research. In addition, we will appoint a multidisciplinary, international committee to begin a comprehensive study of the scientific underpinnings and clinical, ethical, legal, and social implications of human gene editing. The committee will consider and recommend standards, guidelines, and practices governing the use of gene-editing technologies in biomedical research and medicine.
We are seeking nominations for both the planning committee for the international summit and the consensus study committee. We invite suggestions for scientists with expertise in molecular and developmental biology...
Related Articles
By Paul Knoepfler, Stat | 06.24.2026
What if you could precisely change the genome of a pre-implantation human embryo and then safely use that embryo to try to generate a healthier person? It’s a wild idea, but one that technology over the past decade has steadily...
By Philip Ball, Quanta Magazine | 06.18.2026
Since its molecular structure was deduced in the 1950s, DNA has been hailed by many biologists as the secret of life. They’ve read and studied the information stored in the DNA found in the cells of living organisms, known as...
By Max Barnhart, Chemical & Engineering News | 06.09.2026
By Shayna Korol, Vox | 06.12.2026
AI company CEOs Sam Altman (OpenAI), Demis Hassabis (Google DeepMind), and Dario Amodei (Anthropic) disagree on a lot, like how fast the technology should develop, the best way to regulate it, and how to prepare society for smarter-than-human AI, among...